Phase III study met primary endpoint INDIANAPOLIS, Feb. 7, 2012 (HSMN NewsFeed) — Eli Lilly and Company (NYSE: LLY ) announced today that a Phase III study, published online by European Urology, showed both Cialis® (tadalafil) and tamsulosin sign…
Biopharmaceuticals, Urology
Eli Lilly, Cialis, tadalafil, tamsulosin, benign prostatic hyperplasia

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “New Study Evaluates Cialis(R) in parallel with Tamsulosin in Guys with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia”
Leave a Comment